Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Hand-held temple massager tested as drug-free stress relief for midlife women

NCT ID NCT07639658

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 04, 2026 · Updated 1 time

Summary

This study tests whether a non-electric, hand-held temple massager—used daily for 4 weeks with a special lotion and optional lavender aromatherapy—can lower stress, improve emotional wellbeing, sleep quality, and overall quality of life in women aged 35 to 65. Participants use the device at home for at least 5 minutes each day and answer surveys through a secure app. There is no placebo group; researchers compare how participants feel before and after the 4-week period.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Temple Massager System (hand-held mechanical massage device with body lotion and optional lavender aromatherapy)
What this could lead to
If it works, this could offer a simple, drug-free way to ease daily stress, tension headaches, and sleep troubles for women in midlife.
What could go wrong
This is a small, single-arm observational study with no placebo group, so results may be due to the placebo effect or natural changes over time. The device is a general wellness product, not a medical treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

68 people

The number who actually took part.

Started

Jun 2026

Finished

Jul 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Women aged 35 to 65 who experience daily stress, anxiety, tension headaches, facial tension, or TMJ-related discomfort, with self-reported headache frequency of two or more per week. Participants must be in good general health, on stable medication regimens if applicable, able to use a personal smartphone or tablet, and willing to use the Temple Massager System daily for 4 weeks. Participants are recruited nationwide through wellness research participant pools, social media advertising, and targeted digital outreach to women in wellness communities.

Ages

35 to 65 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female, aged 35-65 years old, inclusive * Self-reported experience of daily stress, anxiety, tension headaches, facial tension, or TMJ-related discomfort * Headache frequency of 2 or more per week (self-reported) * If taking any prescription medication including SSRIs, anxiolytics, sleep medications, hormonal therapies, or blood pressure medications, must be on a stable dose for at least 4 weeks prior to study enrollment and throughout the course of the study * In good general health at the time of screening (Investigator discretion) * Able to read and understand English * Able to read, understand, and provide informed consent * Able to use a personal smartphone or tablet and access the study platform for daily data entry * Able to receive shipment of the study product at an address within the United States * Willing and able to use the Temple Massager System daily for 4 weeks Exclusion Criteria: * No personal smartphone or tablet, no internet access, or unwilling to use the study platform * Known allergy or sensitivity to lavender oil, mango butter, shea butter, arnica, or St. John's Wort (Note: lavender sensitivity alone is not exclusionary; an aromatherapy sensitivity protocol applies) * Active skin infection or open wounds on the face or temple area * Diagnosed trigeminal neuralgia or other cranial nerve pathology * Diagnosed vascular issues affecting the head or face: temporal arteritis, aneurysm, or cerebrovascular malformations * Bleeding disorders: history of easy bruising or bleeding in the face/head area, or current use of prescribed blood thinners (anticoagulants) such as Warfarin or Eliquis * Any surgery on the jaw, temples, or face within the last 6 months * Active inflammation: current redness, swelling, or extreme tenderness specifically over the temple arteries * Current use of prescription headache medications (triptans, topiramate, muscle relaxants, beta-blockers for migraine prophylaxis, or other prescription medications taken primarily for headache management) * Participants currently taking any prescribed medication for sleep or anxiety must be on a stable dose (no dose changes within the past 30 days) to be eligible; participants not on a stable dose are excluded * Current participation in another interventional study * Diagnosed Generalized Anxiety Disorder (GAD) * Currently pregnant, planning to become pregnant during the study period, or breastfeeding * Planned surgical procedure during the study period * Significant illness, disease, or condition which, in the opinion of the Principal Investigator, may impact the ability to participate in the study or impact the study outcomes * Unlikely for any reason to be able to comply with the study or considered unsuited for participation by the Principal Investigator

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Quality of life are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

insomnia Tension-Type Headache

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • MOQ Collective, Ltd.

    Fairfax, California, 94930, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.